Fas Ligand (FasL, Apo-1L/CD95L) Expression and Clinical Outcome in Papillary Microcarcinoma and Papillary Thyroid Carcinomas with Diameter Smaller than 1.5 Centimeters

Date
2010
Author
Kapran, Y.
Bayraktaroglu, T.
Tanakol, R.
Alagoel, F.
Boztepe, H.
Metadata
Show full item record
Abstract
Context: The presence and the importance of FasL (FasL, APO-1L/CD95L) in papillary microcarcinoma lesions which are smaller than 1.5 cm of the thyroid is unclear.
URI
http://hdl.handle.net/20.500.12627/92573
https://doi.org/10.1055/s-0029-1241205
Collections